» Articles » PMID: 26579803

Functional Inducible Nitric Oxide Synthase Gene Variants Associate With Hypertension: A Case-Control Study in a Finnish Population-The TAMRISK Study

Overview
Specialty General Medicine
Date 2015 Nov 19
PMID 26579803
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Increased inducible nitric oxide synthase (iNOS) activity and expression has been associated with hypertension, but less is known whether the 2 known functional polymorphic sites in the iNOS gene (g.-1026 C/A (rs2779249), g.2087 G/A (rs2297518)) affect susceptibility to hypertension. The objective of this study was to investigate the association between the genetic variants of iNOS and diagnosed hypertension in a Finnish cohort.This study included 320 hypertensive cases and 439 healthy controls. All participants were 50-year-old men and women and the data were collected from the Tampere adult population cardiovascular risk study (TAMRISK). DNA was extracted from buccal swabs and iNOS single nucleotide polymorphisms (SNPs) were analyzed using KASP genotyping PCR. Data analysis was done by logistic regression.At the age of 50 years, the SNP rs2779249 (C/A) associated significantly with hypertension (P = 0.009); specifically, subjects carrying the A-allele had higher risk of hypertension compared to those carrying the CC genotype (OR = 1.47; CI = 1.08-2.01; P = 0.015). In addition, a 15-year follow-up period (35, 40, and 45 years) of the same individuals showed that carriers of the A-allele had more often hypertension in all of the studied age-groups. The highest risk for developing hypertension was obtained among 35-year-old subjects (odds ratio [OR] 3.83; confidence interval [CI] = 1.20-12.27; P = 0.024). Those carrying variant A had also significantly higher readings of both systolic (P = 0.047) and diastolic (P = 0.048) blood pressure during the follow-up. No significant associations between rs2297518 (G/A) variants alone and hypertension were found. However, haplotype analysis of rs2779249 and rs2297518 revealed that individuals having haplotype H3 which combines both A alleles (CA-GA, 19.7% of individuals) was more commonly found in the hypertensive group than in the normotensive group (OR = 2.01; CI = 1.29-3.12; P = 0.002).In conclusion, there was a significant association between iNOS genetic variant (rs2779249) and hypertension in the genetically homogenous Finnish population. Those who carried the rare A-allele of the gene had higher risk for hypertension already at the age of 35 years.

Citing Articles

Striving Towards Equity in Cardiovascular Genomics Research.

Jurado Velez J, Anderson N, Datcher I, Foster C, Jackson P, Hidalgo B Curr Atheroscler Rep. 2025; 27(1):34.

PMID: 39964583 PMC: 11836143. DOI: 10.1007/s11883-025-01277-z.


GETdb: A comprehensive database for genetic and evolutionary features of drug targets.

Zhang Q, He Y, Lu Y, Wei Q, Zhang H, Quan Y Comput Struct Biotechnol J. 2024; 23:1429-1438.

PMID: 38616961 PMC: 11015738. DOI: 10.1016/j.csbj.2024.04.006.


Association of Single-Nucleotide Polymorphisms Rs2779249 (chr17:26128581 C>A) and Rs rs2297518 (chr17: chr17:27769571 G>A) of the Gene with Tension-Type Headache and Arterial Hypertension Overlap Syndrome in Eastern Siberia.

Alyabyeva P, Petrova M, Dmitrenko D, Garganeeva N, Chumakova G, Al-Zamil M Genes (Basel). 2023; 14(2).

PMID: 36833440 PMC: 9957272. DOI: 10.3390/genes14020513.


The Role of Single Nucleotide Variants of and Genes in the Development of the Phenotype of Migraine and Arterial Hypertension.

Moskaleva P, Shnayder N, Petrova M, Kaskaeva D, Gavrilyuk O, Radostev S Brain Sci. 2021; 11(6).

PMID: 34200123 PMC: 8228947. DOI: 10.3390/brainsci11060753.


The Role of Single-Nucleotide Variants of , and Genes in the Comorbidity of Arterial Hypertension and Tension-Type Headache.

Shnayder N, Petrova M, Moskaleva P, Shesternya P, Pozhilenkova E, Nasyrova R Molecules. 2021; 26(6).

PMID: 33809023 PMC: 8002043. DOI: 10.3390/molecules26061556.


References
1.
Doris P . Hypertension genetics, single nucleotide polymorphisms, and the common disease:common variant hypothesis. Hypertension. 2002; 39(2 Pt 2):323-31. DOI: 10.1161/hy0202.104087. View

2.
Pautz A, Art J, Hahn S, Nowag S, Voss C, Kleinert H . Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide. 2010; 23(2):75-93. DOI: 10.1016/j.niox.2010.04.007. View

3.
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S . CaMK4 Gene Deletion Induces Hypertension. J Am Heart Assoc. 2012; 1(4):e001081. PMC: 3487344. DOI: 10.1161/JAHA.112.001081. View

4.
Vanhoutte P . Endothelial dysfunction: the first step toward coronary arteriosclerosis. Circ J. 2009; 73(4):595-601. DOI: 10.1253/circj.cj-08-1169. View

5.
Smith C, Santhanam L, Bruning R, Stanhewicz A, Berkowitz D, Holowatz L . Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive humans. Hypertension. 2011; 58(5):935-42. PMC: 3209704. DOI: 10.1161/HYPERTENSIONAHA.111.178129. View